Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Masjuan

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Journal of Neurointerventional Surgery|December 25, 2017
Mechanical thrombectomy in orally anticoagulated patients with acute ischemic strokeGustavo Zapata-Wainberg, Álvaro Ximénez-Carrillo, Santiago Trillo, et al.
Interventional Neurology|November 25, 2015
Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC RegistryGustavo Zapata-Wainberg, Álvaro Ximénez-Carrillo Rico, Lorena Benavente Fernández, et al.
Parkinsonism & Related Disorders|October 18, 2019
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive studyAraceli Alonso-Canovas, José Ignacio Tembl Ferrairó, Irene Martínez-Torres, et al.
Journal of Comparative Effectiveness Research|February 7, 2023
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxabanFrancisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 6, 2019
Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke PatientsFrancisco Purroy, Ana Vena, Carles Forné, et al.
Cardiology Journal|October 6, 2022
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR studyManuel Anguita Sánchez, Francisco Marín, Jaime Masjuan, et al.
European Neurology|December 15, 2020
Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015Sonia Quintas, Gustavo Zapata-Wainberg, Susana Arias-Rivas, et al.
Frontiers in Neurology|November 16, 2020
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC RegistryRaquel Gutiérrez-Zúñiga, Ricardo Rigual, Gabriel Torres-Iglesias, et al.
Journal of Neurology|August 18, 2018
Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up studyAraceli Alonso-Canovas, Jose Luis Lopez-Sendon Moreno, Javier Buisan, et al.
Vaccines|April 28, 2023
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Journal of Neurointerventional Surgery|December 25, 2017
Mechanical thrombectomy in orally anticoagulated patients with acute ischemic strokeGustavo Zapata-Wainberg, Álvaro Ximénez-Carrillo, Santiago Trillo, et al.
Interventional Neurology|November 25, 2015
Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC RegistryGustavo Zapata-Wainberg, Álvaro Ximénez-Carrillo Rico, Lorena Benavente Fernández, et al.
Parkinsonism & Related Disorders|October 18, 2019
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive studyAraceli Alonso-Canovas, José Ignacio Tembl Ferrairó, Irene Martínez-Torres, et al.
Journal of Comparative Effectiveness Research|February 7, 2023
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxabanFrancisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 6, 2019
Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke PatientsFrancisco Purroy, Ana Vena, Carles Forné, et al.
Cardiology Journal|October 6, 2022
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR studyManuel Anguita Sánchez, Francisco Marín, Jaime Masjuan, et al.
European Neurology|December 15, 2020
Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015Sonia Quintas, Gustavo Zapata-Wainberg, Susana Arias-Rivas, et al.
Frontiers in Neurology|November 16, 2020
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC RegistryRaquel Gutiérrez-Zúñiga, Ricardo Rigual, Gabriel Torres-Iglesias, et al.
Journal of Neurology|August 18, 2018
Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up studyAraceli Alonso-Canovas, Jose Luis Lopez-Sendon Moreno, Javier Buisan, et al.
Vaccines|April 28, 2023
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, et al.
Pageof 11